August 2013 Editor's Picks: Products from Eltherm and Netzsch - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

August 2013 Editor's Picks: Products from Eltherm and Netzsch

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Eltherm
Electronic temperature controllers are designed for demanding applications and high loads.

Eltherm’s electronic temperature controllers include the ELTC-14 with cable glands and the ELTC/H-14 with sockets to connect heated hoses or heating mats. Both models can be used to control the temperature of up to two heating cables with a temperature range from 0–390 °C. The robust controllers have splashproof housings with transparent covers. The signal contact can be operated either as a potential-free alarm, status, or release contact. The controller reliably switches up to 20 amp resistive load using a hybrid relay. An operating voltage of 90–260 volts AC allows the controllers to be used all over the world.

Netzsch
Disperser targets forces to separate agglomerated particles.

The Omega Economic Disperser from Netzsch disperses agglomerated particles in an energy-efficient manner by optimizing turbulence, cavitation, and shear forces. High efficiency leads to less heat development, reduced energy consumption, and lower cooling water consumption. The flow design leads to low wear (even with abrasive substances) and lower maintenance costs. The system can be adapted to different operating conditions or formulations using the adjustable nozzle. The Omega is available in four sizes ranging from 30 L/h to 4000 L/h. The Omega won the Innovation Award for the Plant Engineering and Processing Components category at the Powtech 2013 conference.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here